[The present status of tumor markers in malignant ovarian tumor].
Various serological data comprising 25 items were analyzed on 152 cases of malignant ovarian tumor and 124 cases of bening ovarian tumor. The results revealed that some differences were observed for of these 25 items between both benign and malignant tumors, and especially TPA, CA-125, etc comprised remarkable differences. On recent 99 cases examined for all these items, a synthetic judgment was passed in combination with these serological data. The results suggested that malignant diagnosis can most likely be established for more than 5 item-positivity.
H
H
Nishimura
T
T
Miyoshi
J
J
Hamai
K
K
Miyahara
D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D002272:Carcinoembryonic Antigen / Q000032:analysis; D004796:Clinical Enzyme Tests; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007770:L-Lactate Dehydrogenase / Q000097:blood; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000601:surgery; D012086:Reoperation; D000509:alpha-Fetoproteins / Q000032:analysis
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D002272:Carcinoembryonic Antigen; D007136:Immunoglobulins; D000509:alpha-Fetoproteins; D007770:L-Lactate Dehydrogenase